Skip to Main Content

Author Details

Paolo Radice
Ospedale Circolo e Fondazione Macchi
1969
342
69
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36162533Full-Thickness Macular Hole: Are Supra-RPE Granular Deposits Remnants of Photoreceptors Outer Segments? Clinical Implications.Am J Ophthalmol2023
37503126Understanding the genetic complexity of puberty timing across the allele frequency spectrum.medRxiv2023
37025588A novel <i>BRCA1</i> splicing variant detected in an early onset triple-negative breast cancer patient additionally carrying a pathogenic variant in <i>ATM</i>: A case report.Front Oncol2023
37451831Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel.J Med Genet2023
37444426Spectrum and Frequency of Germline <i>FANCM</i> Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases.Cancers (Basel)2023
37168384Refinement of the assignment to the ACMG/AMP BS3 and PS3 criteria of eight <i>BRCA1</i> variants of uncertain significance by integrating available functional data with protein interaction assays.Front Oncol2023
37262986Male breast cancer risk associated with pathogenic variants in genes other than BRCA1/2: an Italian case-control study.Eur J Cancer2023
36707629FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women.Eur J Hum Genet2023
36824750Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.Res Sq2023
34320204Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores.J Natl Cancer Inst2022
35585550Breast cancer risks associated with missense variants in breast cancer susceptibility genes.Genome Med2022
35356420The Impact of Mediterranean Dietary Intervention on Metabolic and Hormonal Parameters According to <i>BRCA1/2</i> Variant Type.Front Genet2022
36205748Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants.Genet Med2022
35933885Incorporating progesterone receptor expression into the PREDICT breast prognostic model.Eur J Cancer2022
36328784Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study.Br J Sports Med2022
36284197Gene expression-based dissection of inter-histotypes, intra-histotype and intra-tumor heterogeneity in pediatric tumors.Sci Rep2022
34906479Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants.Genet Med2022
35084436Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes.JAMA Oncol2022
35340755Evidence-based efficacy of methotrexate in adult Crohn's disease in different intestinal and extraintestinal indications.Therap Adv Gastroenterol2022
34666080A nationwide study of air pollution from particulate matter and daily hospitalizations for respiratory diseases in Italy.Sci Total Environ2022
32613861Standardized scleral buckling approach in the management of noncomplex primary rhegmatogenous retinal detachment.Eur J Ophthalmol2021
33573335Analysis of Italian <i>BRCA1/2</i> Pathogenic Variants Identifies a Private Spectrum in the Population from the Bergamo Province in Northern Italy.Cancers (Basel)2021
34611289Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.Sci Rep2021
33990587Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.Nat Commun2021
34100114Malignant salivary gland tumours in families with breast cancer susceptibility.Virchows Arch2021
34069208Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?Cancers (Basel)2021
34341517Mendelian randomisation study of smoking exposure in relation to breast cancer risk.Br J Cancer2021
34198301Microscope-Assisted Episcleral Surgery with Encircling Buckles and Chandelier Endoillumination for Primary Rhegmatogenous Retinal Detachment in Phakic and Pseudophakic Patients: A 12-Month Comparative Study.Ophthalmologica2021
34336265OCT Biomarkers in Neovascular Age-Related Macular Degeneration: A Narrative Review.J Ophthalmol2021
33281191Analysis of the mutational status of SIX1/2 and microRNA processing genes in paired primary and relapsed Wilms tumors and association with relapse.Cancer Gene Ther2021
33471991Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.N Engl J Med2021
33022221Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.Am J Hum Genet2020
31723001Association of Genomic Domains in <i>BRCA1</i> and <i>BRCA2</i> with Prostate Cancer Risk and Aggressiveness.Cancer Res2020
33266155BRCA1/2 Variants and Metabolic Factors: Results From a Cohort of Italian Female Carriers.Cancers (Basel)2020
30613976Insight into genetic susceptibility to male breast cancer by multigene panel testing: Results from a multicenter study in Italy.Int J Cancer2019
30135485Correction: Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers.Eur J Hum Genet2019
29945896Premacular membrane formation after scleral buckling for primary rhegmatogenous retinal detachment: prospective study and pathophysiological insights.Br J Ophthalmol2019
31213659Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers.Br J Cancer2019
31176273Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives.Crit Rev Oncol Hematol2019
31548585Publisher Correction: Shared heritability and functional enrichment across six solid cancers.Nat Commun2019
31336362Evaluation of CYP17A1 and CYP1B1 polymorphisms in male breast cancer risk.Endocr Connect2019
30737679The association between weight at birth and breast cancer risk revisited using Mendelian randomisation.Eur J Epidemiol2019
30832263Usefulness and Limitations of Comprehensive Characterization of mRNA Splicing Profiles in the Definition of the Clinical Relevance of <i>BRCA1/2</i> Variants of Uncertain Significance.Cancers (Basel)2019
30962250Towards controlled terminology for reporting germline cancer susceptibility variants: an ENIGMA report.J Med Genet2019
30683880Shared heritability and functional enrichment across six solid cancers.Nat Commun2019
30312457Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study.J Natl Cancer Inst2019
30696104GFP-Fragment Reassembly Screens for the Functional Characterization of Variants of Uncertain Significance in Protein Interaction Domains of the BRCA1 and BRCA2 Genes.Cancers (Basel)2019
28837162Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility.Genet Med2018
29915430A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.Nat Genet2018
30204945BRCA1 and BRCA2 5' noncoding region variants identified in breast cancer patients alter promoter activity and protein binding.Hum Mutat2018
  • 1 - 50 of 342

Recommended Authors

Frederick National Laboratory for Cancer Research (FNLCR), Inc.
Career Start Year 2012
Number of shared co-authors 25
Curie Institute Hospital Group
Career Start Year 2008
Number of shared co-authors 3
QIMR Berghofer Medical Research Institute
Career Start Year 2005
Number of shared co-authors 58
National Cancer Institute, Frederick National Laboratory for Cancer Research
Career Start Year 2005
Number of shared co-authors 45
Guardant Health Inc.
Career Start Year 2004
Number of shared co-authors 21
The Ohio State University Comprehensive Cancer Center, Comprehensive Cancer Center
Career Start Year 2002
Number of shared co-authors 22
Universitat Pompeu Fabra
Career Start Year 1999
Number of shared co-authors 21
University of Washington, USA Brotman Baty Institute for Precision Medicine
Career Start Year 1999
Number of shared co-authors 21
Memorial University
Career Start Year 1999
Number of shared co-authors 7
AC Camargo Cancer Center
Career Start Year 1998
Number of shared co-authors 16
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 6
Center for Applied Medical Research.
Career Start Year 1995
Number of shared co-authors 38
Novartis Pharmaceuticals
Career Start Year 1995
Number of shared co-authors 4
Center for Cancer Research, National Cancer Institute
Career Start Year 1995
Number of shared co-authors 28
University of British Columbia
Career Start Year 1994
Number of shared co-authors 103
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 46
Ontario Institute for Cancer Research
Career Start Year 1991
Number of shared co-authors 103
Stanford University
Career Start Year 1989
Number of shared co-authors 20
University of Washington
Career Start Year 1988
Number of shared co-authors 12
National Human Genome Research Institute, National Institutes of Health
Career Start Year 1988
Number of shared co-authors 31
National Human Genome Research Institute, National Institutes of Health
Career Start Year 1988
Number of shared co-authors 54
Mt Sinai Hospital
Career Start Year 1988
Number of shared co-authors 17
Center for Bioinformatics, University of Oslo
Career Start Year 1987
Number of shared co-authors 14
Aix Marseille Universite, INSERM GMGF UMR 1
Career Start Year 1987
Number of shared co-authors 35
Institute of Human Genetics, University Hospital Magdeburg
Career Start Year 1985
Number of shared co-authors 0
Baylor College of Medicine
Career Start Year 1984
Number of shared co-authors 42
Universidad de Alcala
Career Start Year 1983
Number of shared co-authors 79
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1983
Number of shared co-authors 4
USA The Jackson Laboratory Cancer Center
Career Start Year 1982
Number of shared co-authors 6
Baylor College of Medicine
Career Start Year 1982
Number of shared co-authors 31

Collaborators

Fondazione IRCCS Istituto Nazionale dei Tumori
Co-authored papers 131
Mayo Clinic
Co-authored papers 121
University of Cambridge
Co-authored papers 119
University of Toronto
Co-authored papers 114
Instituto de Salud Carlos III
Co-authored papers 112
QIMR Berghofer Medical Research Institute
Co-authored papers 112
Pomeranian Medical University
Co-authored papers 90
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 85
German Cancer Research Center (DKFZ)
Co-authored papers 82
Otto-Friedrich-University Bamberg
Co-authored papers 77
Co-authored papers 76
Co-authored papers 76
Co-authored papers 74
Co-authored papers 73
National Cancer Institute
Co-authored papers 69
Co-authored papers 67
University of California irvine
Co-authored papers 62
University of Utah
Co-authored papers 61
Faculty of Clinical Medicine, University of Oslo
Co-authored papers 61
University of Southern California
Co-authored papers 61
Co-authored papers 60
QIMR Berghofer Medical Research Institute
Co-authored papers 59
Perelman School of Medicine, University of Pennsylvania, USA Abramson Cancer Center
Co-authored papers 57
The Usher Institute, The University of Edinburgh
Co-authored papers 57
Familial Cancer Clinical Unit, Spanish National Cancer Research Centre
Co-authored papers 56
Co-authored papers 50
Co-authored papers 50
National Cancer Institute, National Institutes of Health
Co-authored papers 48
Co-authored papers 47
Erasmus Medical Center
Co-authored papers 46